Anna Lligoña

958 total citations
38 papers, 663 citations indexed

About

Anna Lligoña is a scholar working on Epidemiology, Pathology and Forensic Medicine and Hepatology. According to data from OpenAlex, Anna Lligoña has authored 38 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Epidemiology, 20 papers in Pathology and Forensic Medicine and 9 papers in Hepatology. Recurrent topics in Anna Lligoña's work include Alcohol Consumption and Health Effects (20 papers), Substance Abuse Treatment and Outcomes (14 papers) and Liver Disease Diagnosis and Treatment (12 papers). Anna Lligoña is often cited by papers focused on Alcohol Consumption and Health Effects (20 papers), Substance Abuse Treatment and Outcomes (14 papers) and Liver Disease Diagnosis and Treatment (12 papers). Anna Lligoña collaborates with scholars based in Spain, United States and Finland. Anna Lligoña's co-authors include Antoni Gual, Joan Colom, Lluïsa Ortega, Juan Llopis, Hugo López‐Pelayo, Ramón Bataller, José Altamirano, Juan Caballería, Javier Michelena and Pere Ginès and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Journal of Hepatology.

In The Last Decade

Anna Lligoña

35 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Lligoña Spain 15 413 325 106 86 84 38 663
Nghi Phung Australia 11 477 1.2× 135 0.4× 185 1.7× 65 0.8× 33 0.4× 20 755
Hélène Donnadieu‐Rigole France 11 291 0.7× 238 0.7× 135 1.3× 29 0.3× 20 0.2× 40 467
Noeline Latt Australia 8 243 0.6× 69 0.2× 105 1.0× 51 0.6× 29 0.3× 10 538
Maximilien X. Rehm Canada 10 480 1.2× 353 1.1× 18 0.2× 45 0.5× 178 2.1× 11 697
Sylvain Baillot France 5 134 0.3× 118 0.4× 26 0.2× 55 0.6× 44 0.5× 8 396
Zev W. Chayes United States 8 214 0.5× 269 0.8× 16 0.2× 23 0.3× 30 0.4× 12 582
P Devenyi Canada 13 166 0.4× 154 0.5× 16 0.2× 74 0.9× 15 0.2× 28 554
Marie‐Claude Brindisi France 16 178 0.4× 34 0.1× 30 0.3× 30 0.3× 15 0.2× 48 617
Chaim S. Abittan United States 7 242 0.6× 241 0.7× 58 0.5× 4 0.0× 30 0.4× 11 531
Carla Marienfeld United States 14 88 0.2× 33 0.1× 16 0.2× 38 0.4× 67 0.8× 36 599

Countries citing papers authored by Anna Lligoña

Since Specialization
Citations

This map shows the geographic impact of Anna Lligoña's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lligoña with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lligoña more than expected).

Fields of papers citing papers by Anna Lligoña

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lligoña. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lligoña. The network helps show where Anna Lligoña may publish in the future.

Co-authorship network of co-authors of Anna Lligoña

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lligoña. A scholar is included among the top collaborators of Anna Lligoña based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lligoña. Anna Lligoña is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oliveras, Clara, Anna Lligoña, Lluïsa Ortega, et al.. (2026). MyWayUp : A Digital Intervention for Alcohol Use Disorder in Patients With Alcohol‐Related Liver Disease—Results From an RCT. Liver International. 46(2). e70506–e70506. 1 indexed citations
2.
Balcells‐Oliveró, Mercè, Ramón Bataller, Jordi Gratacós‐Ginès, et al.. (2024). Multiplatform web app (My Way Up) plus motivational interviewing for improving treatment retention in patients with onset of alcohol-related liver disease and alcohol use disorder – an example of participatory research. Digital Health. 10. 599886499–599886499. 3 indexed citations
3.
Gratacós‐Ginès, Jordi, Martina Pérez, Roger Borràs, et al.. (2023). Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: Results from a systematic review and meta-analysis. Hepatology. 79(2). 368–379. 15 indexed citations
4.
López‐Pelayo, Hugo, et al.. (2021). Factors Affecting Quality of Life in Liver Transplant Candidates: An Observational Study. SHILAP Revista de lepidopterología. 2(1). 64–74. 1 indexed citations
5.
Gual, Antoni, Jordi Colmenero, Anna Lligoña, et al.. (2020). Active Smoking Before Liver Transplantation in Patients with Alcohol Use Disorder: Risk Factors and Outcomes. Journal of Clinical Medicine. 9(9). 2710–2710. 6 indexed citations
6.
Barrio, Pablo, Antoni Gual, Anna Lligoña, et al.. (2020). Phosphatidylethanol for Monitoring Alcohol Use in Liver Transplant Candidates: An Observational Study. Journal of Clinical Medicine. 9(9). 3060–3060. 14 indexed citations
7.
Ortega, Lluïsa, et al.. (2020). Adicciones: viejas terapias grupales (TG) y nuevos pacientes. Adicciones. 32(3). 225–227. 1 indexed citations
8.
López‐Pelayo, Hugo, et al.. (2019). Call for Action: Benzodiazepine Prescription Prevalence Analysis Shows Off-Label Prescription in One in Eleven Citizens. European Addiction Research. 25(6). 320–329. 10 indexed citations
9.
López‐Pelayo, Hugo, Laia Miquel, José Altamirano, et al.. (2018). Treatment retention in a specialized alcohol programme after an episode of alcoholic hepatitis: Impact on alcohol relapse. Journal of Psychosomatic Research. 116. 75–82. 17 indexed citations
10.
11.
Londoño, María‐Carlota, Christian Manzardo, Antoni Rimola, et al.. (2016). IFN-free therapy for HIV/HCV-coinfected patients within the liver transplant setting. Journal of Antimicrobial Chemotherapy. 71(11). 3195–3201. 6 indexed citations
12.
López‐Pelayo, Hugo, Laia Miquel, José Altamirano, et al.. (2016). Alcohol consumption in upper aerodigestive tract cancer: Role of head and neck surgeons' recommendations. Alcohol. 51. 51–56. 10 indexed citations
13.
Gual, Antoni, et al.. (2009). Treatment for Alcohol Dependence in Catalonia: Health Outcomes and Stability of Drinking Patterns over 20 Years in 850 Patients. Alcohol and Alcoholism. 44(4). 409–415. 47 indexed citations
14.
Lligoña, Anna, et al.. (2009). Guía clínica de evaluación de pacientes con conductas adictivas para trasplante hepático. Gastroenterología y Hepatología. 32(3). 155–161. 9 indexed citations
15.
Marsillach, Judit, Natàlia Ferré, Maria Carme Vila, et al.. (2007). Serum paraoxonase-1 in chronic alcoholics: Relationship with liver disease. Clinical Biochemistry. 40(9-10). 645–650. 54 indexed citations
16.
17.
Gual, Antoni, et al.. (2004). Tratamiento del alcoholismo y su impacto a largo plazo. Resultados a 10 años de un estudio longitudinal prospectivo de 850 pacientes. Medicina Clínica. 123(10). 364–369. 11 indexed citations
18.
Ortega, Lluïsa, et al.. (2000). Eficacia de la terapia de grupo para alcohólicos. Resultados de un ensayo clínico controlado. Medicina Clínica. 115(4). 126–131. 17 indexed citations
19.
Lligoña, Anna. (2000). Benzodiacepinas en toxicómanos: ¿Problema o solución?. Adicciones. 12(4). 457–459.
20.
Gual, Antoni, et al.. (1999). Does the concept of a standard drink apply to viticultural societies?. Alcohol and Alcoholism. 34(2). 153–160. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nghi Phung Breakdown of academic impact, for papers by Hélène Donnadieu‐Rigole Breakdown of academic impact, for papers by Noeline Latt Breakdown of academic impact, for papers by Maximilien X. Rehm Breakdown of academic impact, for papers by Sylvain Baillot Breakdown of academic impact, for papers by Zev W. Chayes Breakdown of academic impact, for papers by P Devenyi Breakdown of academic impact, for papers by Marie‐Claude Brindisi Breakdown of academic impact, for papers by Chaim S. Abittan Breakdown of academic impact, for papers by Carla Marienfeld
Rankless by CCL
2026